Drug Type Small molecule drug |
Synonyms Cryptotanshinon, Cryptotanshinone, Tanshinone C + [2] |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20O3 |
InChIKeyGVKKJJOMQCNPGB-JTQLQIEISA-N |
CAS Registry35825-57-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Phase 2 | - | - | |
Liver Cirrhosis | Phase 2 | KR | - | |
Nonalcoholic Steatohepatitis | Phase 2 | KR | - | |
Obesity | Phase 2 | KR | - |